Sydney Uni mental health biotech banks $14.5 million Series B
A Sydney biotechnology startup tackling behavioural and psychological symptoms in illnesses such as dementia and substance abuse has raised $14.5m in a Series B. The raise for Kinoxis Therapeutics, cofounded by researchers from the chemistry and psychology faculties at Sydney University, was backed by pioneering venture fund Uniseed, UniSuper, the university, Stoic VC, and US-based Avicella… Read more »